U S Physical Therapy (USPH) Cash & Equivalents (2010 - 2026)

U S Physical Therapy (USPH) has 17 years of Cash & Equivalents data on file, last reported at $28.4 million in Q1 2026.

• Quarterly Cash & Equivalents fell 27.42% year-over-year to $28.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.4 million (down 27.42% YoY) and the FY2025 annual result came in at $35.6 million, down 14.0% from the prior year.
• Cash & Equivalents eased to $28.4 million in Q1 2026 per USPH's latest filing, from $35.6 million in the prior quarter.
• The five-year high for Cash & Equivalents was $160.7 million in Q2 2023, with the low at $24.2 million in Q1 2022.
• Average Cash & Equivalents over 5 years is $71.1 million, with a median of $39.2 million recorded in 2025.
• Year-over-year, Cash & Equivalents soared 383.72% in 2023 and tumbled 73.41% in 2025.
• U S Physical Therapy's Cash & Equivalents stood at $31.6 million in 2022, then soared by 383.72% to $152.8 million in 2023, then slumped by 72.94% to $41.4 million in 2024, then decreased by 14.0% to $35.6 million in 2025, then declined by 20.05% to $28.4 million in 2026.
• Business Quant data shows USPH's Cash & Equivalents at $28.4 million in Q1 2026, $35.6 million in Q4 2025, and $31.1 million in Q3 2025.